Beconase aq and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Beconase aq (beclomethasone dipropionate monohydrate), especially for people who are female, 60+ old, also take Lantus, and have Indigestion.

The phase IV clinical study analyzes which people have Fainting when taking Beconase aq. It is created by eHealthMe based on reports of 1,270 people who have side effects when taking Beconase aq from the FDA, and is updated regularly.

What is Beconase aq?

Beconase aq has active ingredients of beclomethasone dipropionate monohydrate. It is often used in allergies. eHealthMe is studying from 1,293 Beconase aq users. Check the latest studies of Beconase aq.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,447 drugs and 3,548 conditions by eHealthMe. Check the latest studies of Fainting.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

1,270 people reported to have side effects when taking Beconase aq.
Among them, 11 people (0.87%) have Fainting.

Among these 11 people:

What is the gender of people who have Fainting when taking Beconase aq? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Fainting when taking Beconase aq? *

What are other drugs people take besides Beconase aq? *

What are other side effects people have besides Fainting? *

Urinary Tract Infection: 7 people, 63.64%
Muscle Rigidity (muscle stiffness): 5 people, 45.45%
Confusional State: 5 people, 45.45%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 5 people, 45.45%
Body Temperature Increased: 5 people, 45.45%
White Blood Cell Count Increased: 4 people, 36.36%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 4 people, 36.36%
Platelet Count Increased: 4 people, 36.36%
Post-Traumatic Stress Disorder: 2 people, 18.18%
Dementia (madness): 2 people, 18.18%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 36.36%
Indigestion: 4 people, 36.36%
High Blood Cholesterol: 3 people, 27.27%
Diabetes: 3 people, 27.27%
Mood Swings (an extreme or rapid change in mood): 3 people, 27.27%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 3 people, 27.27%
Sinus Disorder (disease of sinus): 1 person, 9.09%
Cardiac Disorder: 1 person, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%
Drowsiness: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Beconase aq and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Beconase aq:

Beconase aq (1,293 reports)

Fainting treatments and more:

Fainting (131,321 reports)

How severe was Fainting and when was it recovered:

Fainting in Beconase aq

Expand to all the drugs that have ingredients of beclomethasone dipropionate monohydrate:

Fainting and drugs with ingredients of beclomethasone dipropionate monohydrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Beconase aq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,447 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,548 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate monohydrate (the active ingredients of Beconase aq) and Beconase aq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.